DG
Therapeutic Areas
Divincell Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TSG-RESCUE™ | Cancers with p53 tumor suppressor gene mutations | Pre-clinical |
| ONCOEDIT™ | Cancers driven by oncogenic mutations (e.g., KRAS G12D/V/C) | Pre-clinical |
| PEP-CAR™ | Cancers (via in vivo generation of CAR-T cells) | Pre-clinical |